Lucid Diagnostics Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
LUCD Company Description
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
LUCD Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view LUCD Smart Score
Score Breakdown
LUCD Company Description
Show More
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of LUCD by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by LUCD's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of LUCD in WallStreetBets Daily Discussion
LUCD News
Recent insights relating to LUCD
CNBC Recommendations
Recent picks made for LUCD stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in LUCD
Corporate Flights
Flights by private jets registered to LUCD
Our Analysis